The mean serum level of sHLA-G in NSCLC patients (53.3 ± 4.6 U/ml) was significantly increased compared to that found in controls (8.36 ± 0.4 U/ml), P< 0.0001 (Fig 1). This evidence concerns the gene HLA-G and non-small cell lung carcinoma.